1. Home
  2. VYGR vs ESCA Comparison

VYGR vs ESCA Comparison

Compare VYGR & ESCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.92

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo Escalade Incorporated

ESCA

Escalade Incorporated

HOLD

Current Price

$17.92

Market Cap

199.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
ESCA
Founded
2013
1922
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
199.9M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
VYGR
ESCA
Price
$3.92
$17.92
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$17.00
N/A
AVG Volume (30 Days)
783.0K
28.0K
Earning Date
06-10-2026
01-01-0001
Dividend Yield
N/A
3.55%
EPS Growth
N/A
6.45
EPS
N/A
0.99
Revenue
$10,135,000.00
$180,541,000.00
Revenue This Year
$54.19
$2.87
Revenue Next Year
$20.22
N/A
P/E Ratio
N/A
$18.03
Revenue Growth
N/A
2.71
52 Week Low
$2.65
$11.41
52 Week High
$5.55
$18.40

Technical Indicators

Market Signals
Indicator
VYGR
ESCA
Relative Strength Index (RSI) 46.21 78.36
Support Level $3.60 $13.64
Resistance Level $4.43 N/A
Average True Range (ATR) 0.33 0.72
MACD 0.01 0.31
Stochastic Oscillator 10.90 92.86

Price Performance

Historical Comparison
VYGR
ESCA

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ESCA Escalade Incorporated

Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.

Share on Social Networks: